1.
Surg Oncol Clin N Am
; 29(1): 15-21, 2020 01.
Artículo
en Inglés
| MEDLINE
| ID: mdl-31757310
RESUMEN
Lung cancer remains second most common cancer in men and women in the United States. More than 50% of patients are diagnosed in the advanced stage. Traditionally, chemotherapy has been the backbone of management of stage IV lung cancer. A better understanding of the molecular pathogenesis has led to rapid development of targeted therapy and immunotherapy. This has led to significant improvement in survival of patients with lung cancer stages III to IV. These drugs are being studied in early stage lung cancer. Several trials are ongoing to improve the survival and quality of life of our patients.
Asunto(s)
Antineoplásicos/uso terapéutico , Biomarcadores de Tumor/genética , Neoplasias Pulmonares/tratamiento farmacológico , Terapia Molecular Dirigida/métodos , Farmacogenética/métodos , Medicina de Precisión/tendencias , Humanos , Neoplasias Pulmonares/genética , Medicina de Precisión/métodos
2.
Clin Lymphoma Myeloma Leuk
; 14(4): e141-3, 2014 Aug.
Artículo
en Inglés
| MEDLINE
| ID: mdl-24630920